Advanced search
1 file | 21.67 MB Add to list

Epidrugs in cancer : epigenetic profiling to improve treamtent for T-cell lymphoblastic leukemia and lymphoma

Lien Provez (UGent)
(2023)
Author
Promoter
(UGent) , (UGent) and (UGent)
Organization

Downloads

  • (...).pdf
    • full text (Published version)
    • |
    • UGent only (changes to open access on 2028-08-29)
    • |
    • PDF
    • |
    • 21.67 MB

Citation

Please use this url to cite or link to this publication:

MLA
Provez, Lien. Epidrugs in Cancer : Epigenetic Profiling to Improve Treamtent for T-Cell Lymphoblastic Leukemia and Lymphoma. Ghent University. Faculty of Medicine and Health Sciences, 2023.
APA
Provez, L. (2023). Epidrugs in cancer : epigenetic profiling to improve treamtent for T-cell lymphoblastic leukemia and lymphoma. Ghent University. Faculty of Medicine and Health Sciences, Ghent, Belgium.
Chicago author-date
Provez, Lien. 2023. “Epidrugs in Cancer : Epigenetic Profiling to Improve Treamtent for T-Cell Lymphoblastic Leukemia and Lymphoma.” Ghent, Belgium: Ghent University. Faculty of Medicine and Health Sciences.
Chicago author-date (all authors)
Provez, Lien. 2023. “Epidrugs in Cancer : Epigenetic Profiling to Improve Treamtent for T-Cell Lymphoblastic Leukemia and Lymphoma.” Ghent, Belgium: Ghent University. Faculty of Medicine and Health Sciences.
Vancouver
1.
Provez L. Epidrugs in cancer : epigenetic profiling to improve treamtent for T-cell lymphoblastic leukemia and lymphoma. [Ghent, Belgium]: Ghent University. Faculty of Medicine and Health Sciences; 2023.
IEEE
[1]
L. Provez, “Epidrugs in cancer : epigenetic profiling to improve treamtent for T-cell lymphoblastic leukemia and lymphoma,” Ghent University. Faculty of Medicine and Health Sciences, Ghent, Belgium, 2023.
@phdthesis{01H956EKDFG6696CFSGK0832BK,
  author       = {{Provez, Lien}},
  language     = {{eng}},
  pages        = {{XXVIII, 278}},
  publisher    = {{Ghent University. Faculty of Medicine and Health Sciences}},
  school       = {{Ghent University}},
  title        = {{Epidrugs in cancer : epigenetic profiling to improve treamtent for T-cell lymphoblastic leukemia and lymphoma}},
  year         = {{2023}},
}